Survey of the Relationship between Fatty Liver Disease in Men by Ultrasound and Serum Ferritin Level
Archives of Advances in Biosciences,
Vol. 13 No. 2 (2022),
1 Dey 2022
,
Page 1-7
https://doi.org/10.22037/aab.v13i1.36122
Abstract
Introduction: The most common hepatic disease is fatty liver. Raised serum ferritin levels are often described as an indicator of liver function. The present study aimed to evaluate the correlation between fatty liver in men by ultrasound and serum ferritin levels in patients referred to Imam Khomeini Hospital in Jiroft in 2020.
Materials and Methods: In this case series study, there is both a descriptive and an analytical component. The study population consisted of all male patients with fatty liver. Patients were included in the study after being visited by a specialist and thus diagnoses their fatty liver were mades by ultrasound. After clinical examination and diagnosis of fatty liver, patients were prepared on a fasting basis for Paraclinical tests (serum levels of iron, and ferritin). After collecting data from patient surveys based on a researcher-made checklist, the data were entered into SPSS V23 (22).
Results: The mean age of patients was 46.8± 16.7. 27. There was a statistically significant correlation between ferritin level and disease severity based on the ultrasound view (P-value = 0.000). Also, there was a significant correlation between serum iron level and disease severity based on the ultrasound view (P-value = 0.005).
Conclusion: The present study findings indicate a correlation between the severity of fatty liver disease and the level of serum ferritin and iron. Therefore, we need to pay special attention to the level of these indicators in patients with fatty liver.
- Fatty liver, Ferritin, Serum
How to Cite
References
Guillot A, Tacke F. Liver macrophages: old dogmas and new insights. Hepatol Commun. 2019; 3(6):730-43. [DOI:10.1002/hep4.1356]
Wang S, Zhang J, Zhu L, Song L, Meng Z, Jia Q, et al. Association between liver function and metabolic syndrome in Chinese men and women. Sci Rep. 2017; 7:1-9. [DOI: 10.1038/srep44844]
Koyama Y, Brenner DA. Liver inflammation and fibrosis. J Clin Invest. 2017; 127(1):55-64. [DOI: 10.1172/JCI88881] [PMID] [PMCID]
Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019; 70(1):151-71. [DOI: 10.1016/j.jhep.2018.09.014] [PMID]
Eslam M, Sanyal AJ, George J, Panel IC. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020; 158(7):1999-2014. [DOI:10.1053/j.gastro.2019.11.312] [PMID]
Kuchay MS, Choudhary N, Mishra SK, Misra A. Nonalcoholic fatty liver disease should be considered for treatment allocation in standard management algorithms for type 2 diabetes. Diabetes Metab Syndr. 2020; 14(6):2233-9. [DOI:10.1016/j.dsx.2020.11.015] [PMID]
Kamran SM, Ahmad M, Ayaz SB, Ahmad I. Frequency of non-alcoholic fatty liver disease in newly diagnosed cases of hepatitis c virus infection and its correlation with genotypes in normal weight patients. Pak Armed Forces Med J. 2018; 68(5):1444-48. https://www.pafmj.org/ index.php/PAFMJ/article/view/2344
Hyysalo JE. Prevalence and Genetics of Non-Alcoholic Fatty Liver Disease. Helsinki; 2017. https://helda.helsinki.fi/handle/10138/228381
Li B, Zhang C, Zhan YT. Nonalcoholic fatty liver disease cirrhosis: a review of its epidemiology, risk factors, clinical presentation, diagnosis, management, and prognosis. Can J Gastroenterol Hepatol. 2018; 2018:1-8. [DOI:10.1155/2018/2784537] [PMID] [PMCID]
Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018; 67(1):328-57. [DOI:10.1002/hep.29367] [PMID]
Xiao G, Zhu S, Xiao X, Yan L, Yang J, Wu G. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta‐analysis. Hepatology. 2017; 66(5):1486-501. [DOI:10.1002/hep.29302] [PMID]
Jamali R, Pourshams A, AMINI S, Deyhim MR, Rezvan H, Malekzadeh R. The upper normal limit of serum alanine aminotransferase in Golestan Province, northeast Iran. Arch Iran Med. 2008; 11(6):602-7. https://www.sid.ir/en/Journal/ViewPaper.aspx?ID=122055
Pacifico L, Celestre M, Anania C, Paolantonio P, Chiesa C, Laghi A. MRI and ultrasound for hepatic fat quantification: relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty
liver disease. Acta paediatrica. 2007; 96(4):542-7. [DOI:10.1111/j.1651-2227.2007.00186.x] [PMID]
Matsuura K, Tobe K, Tsuji T. Fatty liver and obesity in university students. Nihon Shokakibyo Gakkai Zasshi. 1995; 92(10):1743-51. [PMID]
Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology. 1999; 30(6):1356-62. [DOI:10.1002/hep.510300604] [PMID]
Lonardo A, Loria P, Leonardi F, Borsatti A, Neri P, Pulvirenti M, et al. Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study. Dig Liver Dis. 2002; 34(3):204-11. [DOI:10.1016/s1590-8658(02)80194-3] [PMID]
Younossi ZM, Gramlich T, Bacon BR, Matteoni CA, Boparai N, O'Neill R, et al. Hepatic iron and nonalcoholic fatty liver disease. Hepatology. 1999; 30(4):847-50. [DOI:10.1002/hep.510300407] [PMID]
Kowdley KV, Belt P, Wilson LA, Yeh MM, Neuschwander‐Tetri BA, Chalasani N, et al. Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic
fatty liver disease. Hepatology. 2012; 55(1):77-85. [DOI:10.1002/hep.24706] [PMID] [PMCID]
Malaguarnera L, Madeddu R, Palio E, Arena N, Malaguarnera M. Heme oxygenase-1 levels and oxidative stress-related parameters in non-alcoholic fatty liver disease patients. J Hepatol. 2005; 42(4):585-91. [DOI:10.1016/j.jhep.2004.11.040] [PMID]
Ruddell RG, Hoang‐Le D, Barwood JM, Rutherford PS, Piva TJ, Watters DJ, et al. Ferritin functions as a proinflammatory cytokine via iron‐independent protein kinase C zeta/nuclear factor kappaB–regulated signaling in rat hepatic stellate cells. Hepatology. 2009; 49(3):887-900. [DOI:10.1002/hep.22716] [PMID] [PMCID]
Ozawa E, Abiru S, Nagaoka S, Yano K, Komori A, Migita K, et al. Ferritin/alanine aminotransferase ratio as a possible marker for predicting the prognosis of acute liver injury. J Gastroenterol Hepatol. 2011; 26(8):1326-32. [DOI:10.1111/j.1440-1746.2011.06743.x] [PMID]
Ludwig J, Viggiano TR, Mcgill DB, Oh B. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc; 1980; 55(7):434-8. [PMID]
Chitturi S, Farrell GC, George J. Non‐alcoholic steatohepatitis in the Asia–Pacific region: Future shock? Gastroenterol. 2004; 19(4):368-74. [DOI:10.1111/j.1440-1746.2003.03252.x]
Merat SH, Rezvan H, Nouraei M, Abou Alghasemi H, Jamali R, Amini Kafiabad S, et al. Seroprevalence and risk factors of hepatitis A virus infection in Iran: a population based study. Arch Iran Med. 2010; 13(2):99-104. https://www.sid.ir/en/Journal/ViewPaper.aspx?ID=168237
Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003; 37(4):917-23. [DOI:10.1053/jhep.2003.50161] [PMID]
Lu H, Zeng L, Liang B, Shu X, Xie D. High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease. Arch Med Res. 2009; 40(7):571-5. [DOI:10.1016/j.arcmed.2009.07.009] [PMID]
Alavian S, Ramezani M, Bazzaz A, Azuzabadi Farahani M, Behnava B, Keshvari M. Frequency of fatty liver and some of its risk factors in asymptomatic carriers of HBV attending the Tehran blood transfusion organization hepatitis clinic. Iran J Endocrinol Metab. 2008; 10(2):99-106. https://www.sid.ir/en/journal/ViewPaper.aspx?ID=117702
Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput J. Excess weight risk factor for alcoholic
liver disease. Hepatology. 1997; 25(1):108-11. [DOI: 10.1002/hep.510250120] [PMID]
Thomopoulos KC, Arvaniti V, Tsamantas AC, Dimitropoulou D, Gogos CA, Siagris D, et al. Prevalence of liver steatosis in patients with chronic hepatitis B: a study of associated factors and of relationship with fibrosis. Eur J Gastroenterol Hepatol. 2006; 18(3):233-7. [DOI: 10.1097/00042737-200603000-00002] [PMID]
- Abstract Viewed: 102 times
- PDF Downloaded: 30 times
- MP3 Downloaded: 9 times